Ethyl 4-chlorophenylalaninate hydrochloride (1:1)
Ethyl 4-chlorophenylalaninate hydrochloride (1:1) structure
|
Common Name | Ethyl 4-chlorophenylalaninate hydrochloride (1:1) | ||
|---|---|---|---|---|
| CAS Number | 52031-05-7 | Molecular Weight | 264.148 | |
| Density | N/A | Boiling Point | 312.2ºC at 760mmHg | |
| Molecular Formula | C11H15Cl2NO2 | Melting Point | 168-170 °C(lit.) | |
| MSDS | Chinese USA | Flash Point | 142.6ºC | |
|
A test to determine the nature and presence of the memory effect columns packed with the amylose tris(3,5-dimethylphenylcarbamate) stationary phase.
J. Chromatogr. A. 1218(37) , 6302-7, (2011) Acid/base mobile phase modifiers affect enantioseparations in ways that are not fully understood yet, for the lack of systematic studies. This makes chiral analysis of some pharmaceuticals difficult to reproduce. Once a column has been exposed to a modifier, ... |
|
|
Involvement of GABAergic non-benzodiazepine sites in the anxiolytic-like and sedative effects of the flavonoid baicalein in mice.
Behav. Brain Res. 221(1) , 75-82, (2011) Baicalein (BA), one of the main flavonoids obtained from the Chinese medicinal herb Scutellaria baicalensis, usually exerts several pharmacological effects. In the central nervous system (CNS), BA exerts a protective effect on neurons against several neuronal... |
|
|
Alteration of lidocaine- or procaine-induced convulsions by manipulation of brain amines.
J. Dent. Res. 60(2) , 182-6, (1981) Lidocaine and procaine seizure thresholds were studied. The i.p. median convulsant dose (CD50) of lidocaine and procaine with saline pre-treatment was 95 and 240 mg/kg, respectively. Dopamine depletion by pre-treatment with d1-alpha-methyl-p-tyrosine plus dih... |